Potentiated Notch signaling due to either loss of a negative regulator or increased expression of the Notch activating ligand Dll4 in the tumor vasculature correlates with tumorigenesis and therapeutic resistance [4, 5, 10, 52, 53]. This evidence concerns the gene DLL4 and neoplasm.